Home » Topics » BioWorld Science

BioWorld Science
RSS

OnCusp licenses ex-China rights to Multitude's CDH6 antibody-drug conjugate

June 9, 2022

Qualigen Therapeutics initiates IND-enabling studies for QN-302

June 9, 2022

FDA clears Passage Bio's IND for PBML-04 for metachromatic leukodystrophy

June 9, 2022

High-throughput proteomics identifies biomarkers of both rheumatoid arthritis and SLE

June 9, 2022

Cilagicin, next-generation antibiotic with activity against MDR isolates

June 9, 2022

Novel polyphenol derivative as potent DYRK1A inhibitor for the treatment of MS

June 9, 2022

Platelet-activating factor receptor antagonists discovered at Boehringer Ingelheim

June 9, 2022

Ningbo Combireg Pharmaceutical Technology presents deuterated anticancer compounds

June 9, 2022

ATP spreads inflammation by activating neural pathway and enhancing IL-6 amplifier

June 9, 2022

French researchers patent gold complexes and their use as antioxidants

June 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...